IP Library Patent Application 13274616
Patent Application
App. No. 13/274,616

SPIROCYCLIC HETEROCYCLIC DERIVATIVES AND METHODS OF THEIR USE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/274,616
Abstract

Spirocyclic heterocyclic derivatives, pharmaceutical compositions containing these compounds, and methods for their pharmaceutical use are disclosed. In certain embodiments, the spirocyclic heterocyclic derivatives are ligands of the δ opioid receptor and may be useful, inter alia, for treating and/or preventing pain, anxiety, gastrointestinal disorders, and other δ opioid receptor-mediated conditions.

Claims (10)

1 - 148 . (canceled)

149 . A method for preventing or treating a urogenital tract disorder, comprising the step of:

administering to a patient in need thereof an effective amount of a compound of the following formula:

or a pharmaceutically acceptable salt or N-oxide thereof.

150 . A method according to claim 149 ,

wherein said urogenital tract disorder is incontinence or overactive bladder.

151 . A method according to claim 150 , wherein said incontinence is stress urinary incontinence or urge urinary incontinence.

152 . A method according to claim 150 , wherein said urogenital tract disorder is overactive bladder.

153 . A method according to claim 150 further comprising the step of:

administering to said patient an effective amount of an agent for the treatment of incontinence.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2015
From: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
To: CALIXA THERAPEUTICS, INC.; ADOLOR CORPORATION; CUBIST PHARMACEUTICALS, INC.
Reel/Frame 036180/0070 →
SECURITY AGREEMENT Recorded Nov 20, 2012
From: CUBIST PHARMACEUTICALS, INC.; ADOLOR CORPORATION; CALIXA THERAPEUTICS, INC.; CUBIST PHARMACEUTICALS HOLDINGS, INC.; CUBIST PHARMACEUTICALS U.S.
To: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
Reel/Frame 029339/0669 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2012
From: DOLLE, ROLAND E.; LE BOURDONNEC, BERTRAND
To: ADOLOR CORPORATION
Reel/Frame 027828/0836 →